Heparin/heparosan synthase from
View Patent ↗The presently claimed and disclosed invention relates, in general, to dual action heparin synthases and, more particularly, to dual action heparin synthases obtained from Pasteurella multocida . The presently claimed and disclosed invention also relates to heparosan, heparin and heparin-like molecules provided by recombinant techniques and methods of using such molecules and also the identification or prediction of heparin synthases or component single action enzymes. The presently claimed and disclosed invention also relates to methods, and molecules produced according to such methods, for using the presently claimed and disclosed heparosan and/or heparin synthase for polymer grafting and the production of non-naturally occurring chimeric polymers incorporating stretches of one or more acidic GAG molecules, such as heparin, chondroitin, hyaluronan, and/or heparosan.
1. A purified nucleic acid segment comprising a coding region encoding enzymatically active heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment is at least one of:
(a) a purified nucleic acid segment encoding the Pasteurella multocida heparin synthase of SEQ ID NO:6;
(b) the purified nucleic acid segment of SEQ ID NO:5;
(c) a purified nucleic acid segment that is at least 90% identical to SEQ ID NO:5; and
(d) a purified nucleic acid segment that hybridizes to a sequence, which is fully complementary to SEQ ID NO:6 under hybridization conditions of 5× Standard Saline Citrate (SSC) at 50° C. overnight, followed by washing in 0.1×SSC at room temperature for 10-60 minutes.
2. A recombinant vector selected from the group consisting of a plasmid, cosmid, phage, integrated cassette and virus vector, wherein the recombinant vector comprises:
a purified nucleic acid segment having a coding region encoding enzymatically active heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment is at least one of:
(a) a purified nucleic acid segment encoding the Pasteurella multocida heparin synthase of SEQ ID NO:6;
(b) the purified nucleic acid segment of SEQ ID NO:5;
(c) a purified nucleic acid segment that is at least 90% identical to SEQ ID NO:5; and
(d) a purified nucleic acid segment that hybridizes to a sequence, which is fully complementary to SEQ ID NO:6 under hybridization conditions of 5×SSC at 50° C. overnight, followed by washing in 0.1×SSC at room temperature for 10-60 minutes.
3. The recombinant vector of claim 2 , wherein the plasmid further comprises an expression vector.
4. The recombinant vector of claim 3 , wherein the expression vector comprises a promoter operatively linked to the enzymatically active heparin synthase coding region.
5. A recombinant host cell, wherein the recombinant host cell is electroporated, transformed, transfected, or transduced to introduce a recombinant vector into the host cell, wherein the recombinant vector comprises:
a purified nucleic acid segment having a coding region encoding enzymatically active heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment is at least one of:
(a) a purified nucleic acid segment encoding the Pasteurella multocida heparin synthase of SEQ ID NO:6;
(b) the purified nucleic acid segment of SEQ ID NO:5;
(c) a purified nucleic acid segment that is at least 90% identical to SEQ ID NO:5; and
(d) a purified nucleic acid segment that hybridizes to a sequence, which is fully complementary to SEQ ID NO:6 under hybridization conditions of 5×SSC at 50° C. overnight, followed by washing in 0.1×SSC at room temperature for 10-60 minutes.
6. The recombinant host cell of claim 5 , wherein the host cell produces heparin.
7. The recombinant host cell of claim 6 , wherein the heparin is unsulfated.
8. The recombinant host cell of claim 6 , wherein the heparin is sulfated.
9. The recombinant host cell of claim 6 , wherein the heparin is epimerized.
10. The recombinant host cell of claim 6 , wherein the heparin is sulfated and epimerized.
11. The recombinant host cell of claim 5 , wherein the recombinant host cell is a prokaryotic cell.
12. The recombinant host cell of claim 5 , wherein the recombinant host cell is a eukaryotic cell.